Aleksandrova LR, Phillips AG, Wang YT (2017a) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42:160175

Article  Google Scholar 

Aleksandrova LR, Phillips AG, Wang YT (2017b) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42:160175

Article  Google Scholar 

Ardinger C, Winkler G, Lapish C, Winkler G et al CC Lapish, NJ GrahameAlcohol, 2021•Elsevier

Bertholomey ML, Nagarajan V, Torregrossa MM (2016) Sex differences in reinstatement of alcohol seeking in response to cues and Yohimbine in rats with and without a history of adolescent corticosterone exposure. Psychopharmacology 233:2277–2287. https://doi.org/10.1007/s00213-016-4278-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertholomey ML, Nagarajan V, Smith DM, Torregrossa MM (2022) Sex- and age-dependent effects of chronic corticosterone exposure on depressive-like, anxiety-like, and fear-related behavior: role of amygdala glutamate receptors in the rat. Front Behav Neurosci 16. https://doi.org/10.3389/FNBEH.2022.950000

Bradizza CM, Stasiewicz PR, Paas ND (2006) Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev 26:162–178. https://doi.org/10.1016/J.CPR.2005.11.005

Article  PubMed  Google Scholar 

Browne CA, Lucki I (2013) Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 4. https://doi.org/10.3389/FPHAR.2013.00161

Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70:27–34. https://doi.org/10.1016/j.neuropharm.2012.12.009

Article  CAS  PubMed  Google Scholar 

Conley AA, Norwood AEQ, Hatvany TC et al (2021) Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis. Psychopharmacology 238:1737–1752. https://doi.org/10.1007/S00213-021-05825-8

Article  CAS  PubMed  Google Scholar 

Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 67:247–257

Article  CAS  PubMed  Google Scholar 

Creeley C, Wozniak DF, Labruyere J et al (2006) Low doses of memantine disrupt memory in adult rats. J Neurosci 26:3923–3932. https://doi.org/10.1523/JNEUROSCI.4883-05.2006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crowley N, Magee S, Feng M, Magee SN, Feng M, Jefferson SJ, Morris CJ, Dao NC, Brockway DF et al B LuscherNeuropharmacology, 2019•Elsevier

Fava GA, Ruini C, Sonino N (2003) Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs 17:1109–1117. https://doi.org/10.2165/00023210-200317150-00005

Article  PubMed  Google Scholar 

Franceschelli, A., Sens, J., Herchick, S., Thelen, C., & Pitychoutis, P. M. (2015). Sex differences in the rapid and the sustainedantidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress. Neuroscience, 290, 49-60.

Gerhard DM, Pothula S, Liu RJ et al (2020) GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions. J Clin Invest 130:1336–1349. https://doi.org/10.1172/JCI130808

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guiraud J, Spanagel R, van den Brink W (2024) Substitution therapy for patients with alcohol dependence: mechanisms of action and efficacy. 175:187–239. https://doi.org/10.1016/BS.IRN.2024.03.005

Hunt WA, Barnett LW, Branch LG (1971) RELAPSE RATES IN ADDICTION PROGRAMS. J Clin Psychol 27:455–456

Article  CAS  PubMed  Google Scholar 

Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA (2018) Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology 142:72–82. https://doi.org/10.1016/J.NEUROPHARM.2018.01.017

Article  CAS  PubMed  Google Scholar 

Johnson JW, Glasgow NG, Povysheva NV (2015) Recent insights into the mode of action of memantine and ketamine. Curr Opin Pharmacol 20:54–63. https://doi.org/10.1016/J.COPH.2014.11.006

Article  CAS  PubMed  Google Scholar 

Kathryn Mchugh R, Weiss RD (2019) Alcohol use disorder and depressive disorders. Alcohol Res 40:e1–e8. https://doi.org/10.35946/ARCR.V40.1.01

Article  Google Scholar 

Kelson M, Burnett JM, Matthews A, Juneja T (2023) Ketamine treatment for alcohol use disorder: A systematic review. Cureus 15. https://doi.org/10.7759/CUREUS.38498

McIntyre RS, Jain R (2024) Glutamatergic modulators for major depression from theory to clinical use. https://doi.org/10.1007/S40263-024-01114-Y. CNS Drugs

Moos RH, Moos BS, Timko C (2006) Gender, treatment and self-help in remission from alcohol use disorders. Clin Med Res 4:163–174. https://doi.org/10.3121/CMR.4.3.163

Article  PubMed  PubMed Central  Google Scholar 

Patwell R, Yang H, Pandey SC, Glover EJ (2021) An operant ethanol self-administration paradigm that discriminates between appetitive and consummatory behaviors reveals distinct behavioral phenotypes in commonly used rat strains. Neuropharmacology 201. https://doi.org/10.1016/J.NEUROPHARM.2021.108836

Pettinati HM (2004) Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 56:785–792. https://doi.org/10.1016/J.BIOPSYCH.2004.07.016

Article  CAS  PubMed  Google Scholar 

Pothula S, Kato T, Liu RJ et al (2021) Cell-type specific modulation of NMDA receptors triggers antidepressant actions. Mol Psychiatry 26:5097–5111. https://doi.org/10.1038/S41380-020-0796-3

Article  CAS  PubMed  Google Scholar 

Rezvani AH, Levin ED, Cauley M et al (2017) Ketamine differentially attenuates alcohol intake in male versus female alcohol preferring (P) rats. J Drug Alcohol Res 6:1–6. https://doi.org/10.4303/JDAR/236030

Article  Google Scholar 

Ruda-Kucerova J, Babinska Z, Luptak M et al (2018) Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats. Neurosci Lett 666:175. https://doi.org/10.1016/J.NEULET.2017.12.055

Article  CAS  PubMed  Google Scholar 

Sabino V, Narayan AR, Zeric T et al (2013a) mTOR activation is required for the anti-alcohol effect of ketamine, but not Memantine, in alcohol-preferring rats. Behav Brain Res 247:9–16. https://doi.org/10.1016/j.bbr.2013.02.030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabino V, Narayan AR, Zeric T et al (2013b) mTOR activation is required for the anti-alcohol effect of ketamine, but not Memantine, in alcohol-preferring rats. Behav Brain Res 247:9–16. https://doi.org/10.1016/j.bbr.2013.02.030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strong CE, Wright KN, Kabbaj M (2019) Sex and individual differences in alcohol intake are associated with differences in ketamine Self-Administration behaviors and nucleus accumbens dendritic spine density. https://doi.org/10.1523/ENEURO.0221-19.2019. eNeuro 6:

Torrens M, Fonseca F, Mateu G, Farré M (2005) Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 78:1–22. https://doi.org/10.1016/J.DRUGALCDEP.2004.09.004

Article  CAS  PubMed  Google Scholar 

Worrell S, Reviews TG- 2021 Undefined therapeutic potential of ketamine for alcohol use disorder. ElsevierSD Worrell, TJ GouldNeuroscience & Biobehavioral Reviews, 2021•Elsevier

Zanos P, Moaddel R, Morris PJ et al (2016a) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481–486. https://doi.org/10.1038/nature17998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanos P, Moaddel R, Morris PJ et al (2016b) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481–486. https://doi.org/10.1038/nature17998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zarate CA, Singh JB, Carlson PJ et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856–864. https://doi.org/10.1001/ARCHPSYC.63.8.856

Article  CAS  PubMed  Google Scholar 

Zhou L, Duan J (2024) The role of NMDARs in the anesthetic and antidepressant effects of ketamine. CNS Neurosci Ther 30. https://doi.org/10.1111/CNS.14464

Zolghadriha A, Anjomshoaa A, Jamshidi MR, Taherkhani F (2024) Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. BMC Psychiatry 24. https://doi.org/10.1186/S12888-024-05716-0